China Money Network’s DealShot provides detailed information on venture capital and private equity deals in China on a daily basis.
Here you can find out where Chinese investors have been investing their money in at around 5pm each workday.
| Company | Round | Amount | Lead Investor | Participants | Company Intro |
|---|---|---|---|---|---|
| XpressBees | Strategic financing | US$100 million | Alibaba Group | XpressBees is a Pune, India-based e-commerce logistics company, providing same/next day delivery, cash on delivery and other customized logistics solutions in India. | |
| Lizhi.FM | Series D | US$50 million | Orchid Asia Group | Evolution Media China | Lizhi.FM is a Chinese radio mobile app developer and podcast sharing platform. |
| Guomai Media | Series B, Series C | US$45.7M | IDG Capital, Bona Film Group Ltd. | Aqua Ventures, HG Capital, Matrix Partners China | Guomai publishes multi-media cultural products for the new middle class in the categories of literature, history, science and religion. |
| AISEC | Strategic financing | US$15 million | Tencent Holdings | AISEC is a Chinese network security service provider. Its core products include security detection system AIScanner and intrusion detection system WebIDS. | |
| Yimi Station | Pre-A | Tens of millions of RMB | undisclosed | Yimi Station is a Shenzhen-based smart food ordering platform. Users can place orders online and food will be delivered to a nearby smart food box, which has automatic temperate control and can be opened with QR code. |
|
| Cihon.cn | Series B | undisclosed | Marathon Venture Partners, Dongfeng Asset Management Co., Ltd | Cihon is a Beijing-based car data provider for carmakers, car insurers and other third-party service providers. |
|
| Huada Empyrean Software | Strategic financing | US$15 million | National Small and Medium-size Enterprises Development Fund (Shenzhen Guozhong Venture Capital Management Co., Ltd) | China Electronics Corporation, Shenzhen Venture Capital Group | Huada Empyrean Software is a Beijing-based electronic design automation (EDA) software developer and solution provider. |
| Frontier Biotech | Series C | US$48 million | Beijing Huaxin Century Investment Group Co., Ltd | Shenzhen Capital Group Co., Ltd, Efung Capital | Frontier Biotech is a Nanjing-based clinical stage pharmaceutical company. It has developed a long-acting peptide drug discovery and development platform that could potentially transform any peptide drug into long-acting agent. |
